EcoDrugPlus

Histone Deacetylase 2

Ensembl ID : ENSEBUG00000007399
Gene Symbol: HDAC2
1 Cross references
211 Possible Orthologues:

Histone Deacetylase 4

Ensembl ID : ENSEBUG00000013086
Gene Symbol: HDAC4
1 Cross references
263 Possible Orthologues:

Histone Deacetylase 8

Ensembl ID : ENSEBUG00000006852
Gene Symbol: HDAC8
1 Cross references
206 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSEBUG00000009754
Gene Symbol: IMPDH1
1 Cross references
335 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSEBUG00000012076
Gene Symbol: ITGB1
1 Cross references
322 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 1

Ensembl ID : ENSEBUG00000012038
Gene Symbol: IDH1
1 Cross references
234 Possible Orthologues:

Isocitrate Dehydrogenase (Nadp(+)) 2

Ensembl ID : ENSEBUG00000013895
Gene Symbol: IDH2
1 Cross references
262 Possible Orthologues:

Kelch-Like Ech-Associated Protein 1b

Ensembl ID : ENSEBUG00000008126
Gene Symbol: KEAP1B
1 Cross references
189 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSEBUG00000014907
Gene Symbol: KDM1A
1 Cross references
214 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSEBUG00000007543
Gene Symbol: MMP2
1 Cross references
210 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSEBUG00000003267
Gene Symbol: MC1R
1 Cross references
158 Possible Orthologues:

Mitogen-Activated Protein Kinase 1

Ensembl ID : ENSEBUG00000010853
Gene Symbol: MAPK1
1 Cross references
214 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).